|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0019196,
umls-concept:C0019682,
umls-concept:C0019699,
umls-concept:C0032659,
umls-concept:C0087111,
umls-concept:C0205099,
umls-concept:C1514811,
umls-concept:C1521970,
umls-concept:C1561577,
umls-concept:C1706462,
umls-concept:C1719822
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2006-2-2
|
|
pubmed:abstractText |
A cross-sectional study was performed during 2004 at a large HIV clinic in Spain to identify HIV-HCV coinfected individuals who might be candidates for HCV therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Alanine Transaminase,
http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Hepatitis B Surface Antigens,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-alpha,
http://linkedlifedata.com/resource/pubmed/chemical/Polyethylene Glycols,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Viral,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Ribavirin,
http://linkedlifedata.com/resource/pubmed/chemical/interferon alfa-2a,
http://linkedlifedata.com/resource/pubmed/chemical/peginterferon alfa-2a
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1528-4336
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
6
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
329-36
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:16452066-Adolescent,
pubmed-meshheading:16452066-Adult,
pubmed-meshheading:16452066-Aged,
pubmed-meshheading:16452066-Alanine Transaminase,
pubmed-meshheading:16452066-Antiviral Agents,
pubmed-meshheading:16452066-Cross-Sectional Studies,
pubmed-meshheading:16452066-Female,
pubmed-meshheading:16452066-Genotype,
pubmed-meshheading:16452066-HIV Infections,
pubmed-meshheading:16452066-HIV-1,
pubmed-meshheading:16452066-Hepacivirus,
pubmed-meshheading:16452066-Hepatitis B Surface Antigens,
pubmed-meshheading:16452066-Hepatitis C, Chronic,
pubmed-meshheading:16452066-Humans,
pubmed-meshheading:16452066-Interferon-alpha,
pubmed-meshheading:16452066-Male,
pubmed-meshheading:16452066-Middle Aged,
pubmed-meshheading:16452066-Polyethylene Glycols,
pubmed-meshheading:16452066-RNA, Viral,
pubmed-meshheading:16452066-Recombinant Proteins,
pubmed-meshheading:16452066-Retrospective Studies,
pubmed-meshheading:16452066-Ribavirin
|
|
pubmed:articleTitle |
Characteristics and prospects for hepatitis C therapy of an HIV-HCV coinfected population followed at a reference HIV center.
|
|
pubmed:affiliation |
Service of Infectious Diseases, Hospital Carlos III, Madrid, Spain.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
